News for Qualigen Therapeutics, Inc. (QLGN)

Qualigen Therapeutics (QLGN) receives a deficiency notice from Nasdaq for delayed filing of Q1 2025 Form 10-Q. This notification adds to existing compli

**media[630883]**

Qualigen Therapeutics (QLGN) faces Nasdaq delisting risk due to a delayed 10-Q filing.

SAN FRANCISCO, CALIFORNIA, May 15, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ”œCompany”) ( GTBP), a clinical stage immuno-oncology company focused o

CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. ( QLGN) (the ”œCompany”) announced today that it received an expected defici

Qualigen Therapeutics receives deficiency notice from Nasdaq (QLGN:NASDAQ)

Canada-based Venus Concept Inc (VERO) is up over 310 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Qualigen Therapeutics (QLGN) stock fell 21% after announcing participation in a funding round for Israeli medtech NanoSynex. Read more here.

**media[526223]**

Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics ( QLGN) (the ”œCompany” or ”œQualigen”) today announced that the Company received

**media[476111]**

Carlsbad, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (QLGN) ("Qualigen" or the "Company"), Qualigen Therapeutics, Inc., is a life scien

**media[453753]**

CARLSBAD, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it will implement a...

Allovir, Inc. (ALVR) experienced a notable stock price increase of 5.06% as per recent data. The share price reached $0.830 with a trading volume of 89,091 shar

Qualigen Therapeutics faces management shake-up as CEO and CFO resign, new appointments made to steer company's future direction.

Shares of Tesla, Inc. TSLA rose sharply in today's pre-market trading after the company reported stronger-than-expected earnings for its third quarter. The aut...

CARLSBAD, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced the closing of its...

CARLSBAD, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced the pricing of a public...